Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
PLoS One. 2023 Aug 29;18(8):e0290812. doi: 10.1371/journal.pone.0290812. eCollection 2023.
Osteogenesis imperfecta (OI) is a hereditary skeletal disease characterized by bone fragility. Areal bone mineral density (BMD), evaluated by dual-energy X-ray absorptiometry (DXA), is used to assess bone brittleness. The height-adjusted BMD Z-score (BMDHAZ) is calculated in children and adolescents with OI to reduce the confounding factor of short stature. However, even with the BMDHAZ, severity evaluation in children and adolescents with OI is challenging because certain abnormalities in bone quality cannot be accurately assessed by BMD analysis. The trabecular bone scores (TBS) and bone mineral apparent density (BMAD), which represent the structural integrity of bone and bone-size-associated BMD, respectively, are associated with fracture risk. Recently, age- and sex-specific reference ranges have been reported, enabling the calculation of Z-scores for children. To evaluate which density measurements show the highest correlation with fracture risk, we analyzed the associations between the Z-scores of TBS, BMAD, and BMDHAZ, fracture rate, and genetic variants. We retrospectively reviewed 42 participants with OI aged 5 to 20 years who underwent DXA. COL1A1/2 pathogenic variants were detected in 41 of the 42 participants. In participants with nonsense and frameshift variants (n = 17) resulting in haploinsufficiency and mild phenotype, the TBS Z-score was negatively correlated with fracture rate (FR) (r = -0.50, p = 0.042). In participants with glycine substitution (n = 9) causing the severe phenotype, the BMAD Z-scores were negatively correlated with FR (r = -0.74, p = 0.022). No correlation between the BMDHAZ and FR was observed in both groups. These findings suggest that the TBS and BMAD are useful in assessing children and adolescents with OI with specific genetic variants.
成骨不全症(OI)是一种遗传性骨骼疾病,其特征为骨骼脆弱。通过双能 X 射线吸收法(DXA)评估的面积骨密度(BMD)用于评估骨骼脆性。OI 患儿和青少年的身高调整骨密度 Z 评分(BMDHAZ)用于降低身高偏矮的混杂因素。然而,即使有了 BMDHAZ,OI 患儿和青少年的严重程度评估仍然具有挑战性,因为骨质量的某些异常无法通过 BMD 分析准确评估。骨小梁评分(TBS)和骨矿密度表观密度(BMAD)分别代表骨骼结构完整性和与骨大小相关的 BMD,与骨折风险相关。最近,已经报道了年龄和性别特异性参考范围,能够为儿童计算 Z 评分。为了评估哪种密度测量与骨折风险相关性最高,我们分析了 TBS、BMAD 和 BMDHAZ 的 Z 评分、骨折率和遗传变异之间的关联。我们回顾性分析了 42 名年龄在 5 至 20 岁的 OI 患者,这些患者均接受了 DXA 检查。在 42 名患者中,有 41 名检测到 COL1A1/2 致病性变异。在导致杂合不足和轻度表型的无义和移码变异(n = 17)的患者中,TBS Z 评分与骨折率(FR)呈负相关(r = -0.50,p = 0.042)。在引起严重表型的甘氨酸替代(n = 9)患者中,BMAD Z 评分与 FR 呈负相关(r = -0.74,p = 0.022)。在这两组患者中,BMDHAZ 与 FR 之间均无相关性。这些发现表明 TBS 和 BMAD 可用于评估具有特定遗传变异的 OI 患儿和青少年。